Evolent Health
EVH
168 hedge funds and large institutions have $1.66B invested in Evolent Health in 2021 Q1 according to their latest regulatory filings, with 28 funds opening new positions, 50 increasing their positions, 64 reducing their positions, and 19 closing their positions.
129% more call options, than puts
Call options by funds: $5.5M | Put options by funds: $2.4M
100% more funds holding in top 10
Funds holding in top 10: 3 → 6 (+3)
47% more first-time investments, than exits
New positions opened: 28 | Existing positions closed: 19
27% more capital invested
Capital invested by funds: $1.31B → $1.66B (+$351M)
4% more funds holding
Funds holding: 161 → 168 (+7)
0.19% more ownership
Funds ownership: 95.05% → 95.24% (+0.19%)
22% less repeat investments, than reductions
Existing positions increased: 50 | Existing positions reduced: 64
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
+$27.5M |
| 2 |
PWAM
Park West Asset Management
San Francisco,
California
|
+$16.6M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$16.2M |
| 4 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
+$10.1M |
| 5 |
JP Morgan Chase
New York
|
+$8.56M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SAM
Silvercrest Asset Management
New York
|
-$12.9M |
| 2 |
Dimensional Fund Advisors
Austin,
Texas
|
-$6.12M |
| 3 |
State Street
Boston,
Massachusetts
|
-$5.99M |
| 4 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
-$5.74M |
| 5 |
GF
Gabelli Funds
Rye,
New York
|
-$5.54M |
EVH Hedge Fund Activity: Q1 2021 in Review
168 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Evolent Health (EVH) for Q1 2021, worth a combined $1.66B — up 27% from $1.31B a quarter earlier.
Buyers outnumbered sellers: 28 funds opened new EVH positions and 19 closed out — a net gain of 9 holders — while 50 added to existing stakes and 64 trimmed.
The largest buyer was Rock Springs Capital Management, opening a new position worth an estimated $27.5M. The largest seller was Silvercrest Asset Management, cutting an estimated $12.9M.
- 168 institutional investors held Evolent Health (EVH) as of Q1 2021, up from 161 in Q4 2020.
- Funds reported $1.66B of Evolent Health stock for Q1 2021, up 27% quarter-over-quarter.
- 28 funds opened new Evolent Health positions in Q1 2021 and 19 closed out, a net change of +9 holders.
- The largest Evolent Health buyer in Q1 2021 was Rock Springs Capital Management, an estimated $27.5M added.
- The largest Evolent Health seller in Q1 2021 was Silvercrest Asset Management, an estimated $12.9M sold.
Based on aggregated 13F filings for Q1 2021.